Category: #COVID-19

Featured image for “COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review”

COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

Published: 23 October 2024 Rahul H. Dave, Heidi Crayton, Augusto Miravalle, Ming-Hui Tai, Kerri Wyse, Katherine Houghton, Abby Hitchens & Regina Berkovich DOWNLOAD THE PDF ABSTRACTIntroductionReal-world data are required to…

Stuart Schlossman

Breakthrough COVID-19 Vaccine Injury Study Links mRNA Vaccines to Triggering Autoimmune Diseases

TrialSite Staff Staff at TrialSite | Quality Journalism Mar. 4, 2023, 2:00 p.m. Physician-investigators at King Fahad University Hospital in…

Stuart Schlossman

COVID-19 Could Trigger MS Via ‘Molecular Mimicry,’ Study Shows

  By Marisa Wexler, MS on 01/10/2023 A protein in the virus that causes COVID-19 is structurally similar to several…

Stuart Schlossman

At-Home OTC COVID-19 Diagnostic Tests / Expiration Date information

 December 14, 2022 General Information About At-Home OTC COVID-19 Diagnostic Tests This page has information about at-home over-the-counter (OTC) COVID-19…

Stuart Schlossman

EVUSHELD is no longer effective against newer Omicron subvariants

 Article provided by: Cherie C Binns RN MSCN As SARS-CoV-2, the virus that causes COVID-19, continues to evolve, monoclonal antibodies are no…

Stuart Schlossman

Video: MS Views NOW – Dietary Approaches for MS, Covid updates for those with Multiple Sclerosis, medication information and more

  Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…

Stuart Schlossman

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

 ORIGINAL RESEARCH article –  Front. Immunol., 05 August 2022    https://doi.org/10.3389/fimmu.2022.926318   — Sec. Vaccines and Molecular Therapeutics –   —————————————– https://www.frontiersin.org/journals/immunology…

Stuart Schlossman

Should you get a Tdap vaccine with MS?

  Most people with MS use disease-modifying therapies (DMTs). These are medications that dampen the effects of your immune system, helping…

Stuart Schlossman

DMT for Multiple Sclerosis Tied to Lower Risk for In-Hospital COVID-19 Mortality

 Mortality among patients with multiple sclerosis (MS) hospitalized for COVID-19 was lower among patients taking disease-modifying therapy (DMT), according to…

Stuart Schlossman

New Bouts of Depression, Anxiety Linked to Pandemic, US Survey Finds

by Marisa Wexler MS | April 11, 2022 Many people with multiple sclerosis (MS) report new bouts of depression and anxiety as a result of…

Stuart Schlossman

Categories

Latest Blog Posts